The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Collecting wisdom: Creating an evidence framework for personalized cancer therapy.
 
Damian Tobias Rieke
No Relationships to Disclose
 
Konrad Friedrich Klinghammer
Honoraria - Glycotope GmbH; Lilly
Consulting or Advisory Role - Glycotope GmbH; Lilly
Travel, Accommodations, Expenses - EPO Berlin GmbH
 
Frederick Klauschen
Honoraria - Novartis
 
Sebastian Ochsenreither
Consulting or Advisory Role - MSD; Novartis
 
Susen Burock
No Relationships to Disclose
 
Alberto Fusi
Honoraria - Bristol-Myers Squibb; Merck
 
Christine Sers
Honoraria - Merck
Travel, Accommodations, Expenses - Merck
 
Korinna Jöhrens
No Relationships to Disclose
 
Michael Hummel
No Relationships to Disclose
 
Verena Waltraut Materna
No Relationships to Disclose
 
Inge Tinhofer
Consulting or Advisory Role - Merck Serono
Research Funding - Merck Serono (Inst); Pfizer (Inst)
 
Manfred Dietel
Honoraria - AstraZeneca; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
Expert Testimony - AstraZeneca; Bristol-Myers Squibb; Roche
 
Reinhold Schäfer
Stock and Other Ownership Interests - Alacris Theranostics
Consulting or Advisory Role - Signature Diagnostics
 
Ulrich Keilholz
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD Oncology; Novartis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck Serono; MSD Oncology; MSD Oncology; Novartis
Research Funding - Merck Serono; Pfizer